Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 215

Results For "API"

2924 News Found

Glamyo Health records ARR of US $ 8 million last fiscal
Startup | April 25, 2022

Glamyo Health records ARR of US $ 8 million last fiscal

It is a multi-speciality healthcare brand which delivers a hassle-free experience for all types of cosmetic procedures and elective surgeries with personalized care


New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19
Biotech | April 25, 2022

New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19

Real-world evidence from more than 850,000 hospitalized patients provides clinical insights on the use of Veklury (remdesivir) as stand of care Covid-19 treatment


Erytech sells U.S. manufacturing facility and enters long-term supply agreement with Catalent
Biotech | April 25, 2022

Erytech sells U.S. manufacturing facility and enters long-term supply agreement with Catalent

Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction


Thermo Fisher opens bioprocessing manufacturing site in Ogden, Utah
News | April 25, 2022

Thermo Fisher opens bioprocessing manufacturing site in Ogden, Utah

The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19


Twenty eight companies commit to Rs 6000 crore at Global Ayush meet
News | April 23, 2022

Twenty eight companies commit to Rs 6000 crore at Global Ayush meet

The commitment is expected to generate over 5.56 lakh jobs and positively impact the lives of more than 76 lakh people, the ministry said


CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer
Biotech | April 23, 2022

CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer

With one of the most diverse lung cancer development programs, Novartis is focused on investments to advance the science, drive treatment and make an impact on patients


IOL Chemicals and Pharmaceuticals commences commercial production of paracetamol
News | April 23, 2022

IOL Chemicals and Pharmaceuticals commences commercial production of paracetamol

All the capex is being met through internal accruals only


USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial
Biotech | April 22, 2022

USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial

The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic


Qvella FAST System and FAST-PBC get CE marked and USFDA listed
Biotech | April 22, 2022

Qvella FAST System and FAST-PBC get CE marked and USFDA listed

With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods


Dr Reddy’s appoints Amit Golash as Global Head-Customer Service & Logistics
People | April 22, 2022

Dr Reddy’s appoints Amit Golash as Global Head-Customer Service & Logistics

He has extensive leadership experience across supply chain and has worked at companies such as Unilever, Flipkart, Colgate-Palmolive & Mondelez